Using oral anti-anxiety medication during second eye cataract surgery
Official title: Pain, Anxiety and Anesthetic Satisfaction for Patient With Different State Anxiety Underwent Cataract Surgery With Topical Anesthesia. An Extension Test of Whether to Use Oral Anti-anxiety Drugs (Alprazolam) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction.
Run by National Taiwan University Hospital · NCT06874452 · Data updated 2026-11-12
This study is testing if taking the anti-anxiety medication XANAX can help people feel less anxious and more comfortable during their second eye cataract surgery compared to a placebo.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | March 25, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | April 24, 2026 |
| Trial ID | NCT06874452 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 80 who are scheduled for cataract surgery on their second eye and do not have contraindications to XANAX.
✕Probably not a fit
Patients with severe corneal diseases, contraindications to surgery, or those who do not experience preoperative anxiety may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of the oral anti-anxiety drug XANAX on patient satisfaction, anxiety, and pain during phacoemulsification cataract surgery. It aims to determine whether oral sedation can provide a safer and more convenient alternative to intravenous sedation, which is commonly used but carries additional risks. Patients undergoing surgery on their second eye will be monitored for their anxiety levels, pain experiences, and overall satisfaction with the procedure. The study will compare outcomes between those receiving XANAX and those receiving a placebo.
Why it matters
Potential benefit: If successful, this study could lead to improved patient comfort and satisfaction during cataract surgery.
How similar studies have gone: Previous studies have shown varying success with oral sedation in surgical settings, but the specific use of XANAX in cataract surgery is less explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age between 18 and 80 years old. 2. Enrolled in "Anxiety and surgery satisfaction for cataract patient with different state anxiety" (Research Ethics Committee Case No.: 202302067MINB). 3. Plan to undergo phacoemulsification and intraocular lens implantation surgery with topical anesthetic on the second eye at the Department of Ophthalmology. 4. Subject who does not have side effect from XANAX. Exclusion Criteria: 1. Presence of any surgery contraindications. 2. Presence of any medication contraindications. 3. Inability to provide clear and complete answers to relevant questionnaires, or expression of no preoperative anxiety during the outpatient visit, or scores below 21 on the STAI-S or STAI-T assessment. 4. Regular use of anti-anxiety medications, sleeping pills, or analgesics before the procedure. 5. Pregnancy or breastfeeding during the preoperative period. 6. Severe corneal diseases, overripe cataracts, small pupils, or lens dislocation leading to difficulties in conventional surgery. 7. Patients under surface anesthesia who cannot fully cooperate with the surgical procedure. 8. Pregnant or uncertain pregnancy status (women under 55 years old to be verbally asked by research team members).
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Chiun Ho Hou, Ph.D — National Taiwan University Hospital
- Study coordinator: Chiun Ho Hou, Ph.D
- Email: chiunhohou@gmail.com
- Phone: +88623123456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of anxiety on satisfaction during cataract surgery
This study tests how anxiety affects pain and satisfaction during cataract surgery and whether taking Xanax before the procedure can help improve comfort for patients.
-
Tropicamide/phenylephrine safety in hospitalized patients
This project will see if certain health factors make hospitalized adults more likely to have side effects after getting tropicamide/phenylephrine eye drops.
-
Identification of Cellular Biomarkers in Rare Eye Diseases
This study tests whether specific gene and protein markers in cells and tears can distinguish adults with rare corneal diseases from others and relate to their eye symptoms.
-
Sublingual melatonin before cataract surgery in older adults
This study will test whether taking sublingual melatonin before cataract surgery helps adults aged 60 and older feel less anxious and sedated while remaining safe.
-
Using Systane COMPLETE to improve dry eye symptoms before and after cataract surgery
This study is testing if using Systane COMPLETE eye drops can help people with dry eyes feel better before and after cataract surgery.
-
Improving eye surface health before cataract surgery with Systane COMPLETE
This study tests if using Systane COMPLETE can help people with dry eyes feel better before cataract surgery and improve their surgery results.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.